Navigation Links
Waters Offers U.S. Water Authorities Complimentary Drinking Water Testing for the Presence of Pharmaceuticals

Baseline Understanding of Exposure Allows for Long-term Monitoring and

Development of Solutions

MILFORD, Mass., March 19 /PRNewswire-FirstCall/ -- Responding to recent reports regarding findings of trace levels of pharmaceuticals found in U.S. drinking water supplies, Waters Corporation (NYSE: WAT) announced today that it will offer qualified U.S. water authorities complimentary drinking water analysis for common over-the-counter and prescription antidepressant pharmaceutical compounds to help assess regional exposure and move towards forward-looking solutions.

"As a provider of analytical technologies capable of detecting trace levels of contaminants in water, food and the environment, Waters(R) is keenly aware of the broad impact that contaminants can have on our natural resources," said Rohit Khanna, Vice President of Worldwide Marketing for the Waters Division. "As scientists, we at Waters believe in the need - and have the solutions - to assess baseline data to measure contamination levels, if any. Through this program we hope to work in cooperation with U.S. water authorities to better assess the public's exposure to pharmaceutical residues and assist them with potential action plans."

For 50 years, Waters has been producing advanced environmental solutions and working with regulatory and government agencies at all levels. For example, the Associated Press reported that the U.S. Environmental Protection Agency (EPA) recently published a method to test for pharmaceutical and personal care products in water, soil, sediment, and biosolids; a method which references Waters solutions throughout. More recently, Waters is applying advance technology to deliver an automated solution with improved throughput for drinking water analysis.

Program Logistics

For a limited time, Waters will offer authorized officials from any U.S. water authority that serves more than 100,000 customers to submit a request for a complimentary test for common over-the-counter and anti-depressant pharmaceutical compounds of their finished water (tap water) by visiting Requests will only be honored from authorized water officials and the results will be held in strict confidence. Waters will not accept requests from third parties.

The intention of these tests is to provide a baseline understanding of exposure to facilitate long-term solutions. These complimentary tests will not be validated or certified, and are only intended as an initial screen for the detection of pharmaceutical residues.

Waters Solutions

Waters will test submitted samples using the AquaAnalysis System, a total system solution designed to detect a range of contaminants in drinking water. The AquaAnalysis System can detect target analytes at or below 10 parts-per- trillion (PPT), easily meeting or exceeding regulatory standards worldwide. The AquaAnalysis System has been shown to improve sample throughput by up to 80 percent by cutting analysis times from between three to five hours to just 30 minutes.

In December 2007, EPA published Method 1694 Pharmaceuticals and Personal Care Products in Water, Soil, Sediment, and Biosolids by HPLC/MS/MS. Using Waters chemistry products, Method 1694 identifies pharmaceuticals and personal care products in environmental samples by high performance liquid chromatography combined with tandem mass spectrometry (HPLC/MS/MS) using isotope dilution and internal standard quantification techniques. This method has been developed for use with aqueous, solid, and biosolids matrices: (

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters is a trademark of Waters Corporation.


Brian J. Murphy

Waters Corporation

Public Relations Manager


SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Out of the woods: Physicians get urban disaster training in forests, gorges and waters
2. Waters Corporation Receives Market Leadership and Product Innovation Awards
3. Extracts of catfish caught in polluted waters cause breast cancer cells to multiply
4. 2007: A Watershed Year for Lupus Research and Education
5. Vanderbilt University Medical Center and Waters Collaborate on Tissue Imaging Research Using SYNAPT HDMS
6. Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008
7. Health care incentive model offers collaborative approach
8. Eye-staining technique offers early detection for dry eye syndrome
9. Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians
10. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
11. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... the only authorized OSHA Training Institute Education Center headquartered in Northern California, has ... workers from extreme heat at their worksites. Employers with workers exposed to ...
(Date:6/27/2016)... ... 27, 2016 , ... "FCPX editors can now reveal their media with growing ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings ... users can now reveal the media of their split screens with growing colorful panels. ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the ... affiliation with Tennessee Counseling Association. This new relationship allows TherapySites to ... Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: